It appears, therefore, that FKN may be upregulated in astrocytes in response to several pro-inflammatory signals, which can occur in conditions such as stroke, multiple sclerosis (MS) and Alzheimer's disease (AD). Here, CX3CL1 is linked to Alzheimer disease.